Overview

  • Product nameAnti-BIRC6 antibody
    See all BIRC6 primary antibodies
  • Description
    Rabbit polyclonal to BIRC6
  • Tested applicationsSuitable for: ICC/IF, WB, IP, IHC-Pmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Chimpanzee, Rhesus monkey, Orangutan
  • Immunogen

    corresponding to BIRC6 (C terminal).
    Database link: Q9NR09

Properties

Applications

Our Abpromise guarantee covers the use of ab19609 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ICC/IF Use a concentration of 5 µg/ml.
WB 1/5000 - 1/15000. Predicted molecular weight: 528 kDa.
IP Use at 1-4 µg/mg of lysate.
IHC-P 1/2000 - 1/10000. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Target

  • FunctionProtects cells from undergoing apoptosis.
  • Tissue specificityExpressed in brain cancer cells.
  • Sequence similaritiesIn the C-terminal section; belongs to the ubiquitin-conjugating enzyme family.
    Contains 1 BIR repeat.
  • Post-translational
    modifications
    Ubiquitinated. Ubiquitination is mediated by the RNF41 E3 ligase and leads to proteasomal degradation, impairing inhibition of apoptosis.
  • Information by UniProt
  • Database links
  • Alternative names
    • Apollon antibody
    • Apollon protein antibody
    • Baculoviral IAP repeat containing 6 antibody
    • Baculoviral IAP repeat containing protein 6 antibody
    • Baculoviral IAP repeat-containing protein 6 antibody
    • BIR repeat containing ubiquitin conjugating enzyme antibody
    • BIRC 6 antibody
    • BIRC6 antibody
    • BIRC6_HUMAN antibody
    • BRUCE antibody
    • FLJ13726 antibody
    • FLJ13786 antibody
    • KIAA1289 antibody
    • Ubiquitin conjugating BIR domain enzyme apollon antibody
    • Ubiquitin-conjugating BIR domain enzyme apollon antibody
    see all

Anti-BIRC6 antibody images

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human breast carcinoma tissue labelling BIRC6 with ab19609 at 1/5000 (0.2µg/ml). Detection: DAB.
  • All lanes : Anti-BIRC6 antibody (ab19609) at 1/10000 dilution

    Lane 1 : HeLa whole cell lysate at 20 µg
    Lane 2 : HeLa whole cell lysate at 50 µg
    Lane 3 : HeLa S100 extract at 20 µg
    Lane 4 : HeLa S100 extract at 50 µg


    Predicted band size : 528 kDa

    Detection of Human BIRC6 by western blot.
    Lane 1:  20 µg of HeLa whole cell lysate.
    Lane 2:  50 µg of HeLa whole cell lysate.
    Lane 3:  20 µg of HeLa S100 extract.
    Lane 4:  50 µg of HeLa S100 extract.

    Affinity purified anti-BIRC antibody (ab19609) was used at a 1/10,000 dilution.

  • Detection of human BIRC6 by Immunoprecipitation. Affinity purified ab19609 used at 2mcg/mg lysate (whole cell lysate (10mg) from HeLa cells. The immunoprecipitate was resolved by SDS-PAGE and stained with Coomassie Blue. The band that is BIRC6 was confirmed by mass spectrometry.
  • ICC/IF image of ab19609 stained HeLa cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab19609, 5µg/ml) overnight at +4°C. The secondary antibody (green) was ab96899, DyLight® 488 goat anti-rabbit IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

References for Anti-BIRC6 antibody (ab19609)

This product has been referenced in:
  • Wilding C  et al. ?-Synuclein antibodies have neuroprotective potential on neuroretinal cells via proteins of the mitochondrial apoptosis pathway. PLoS One 9:e90737 (2014). Read more (PubMed: 24595072) »
  • Lamers F  et al. Identification of BIRC6 as a novel intervention target for neuroblastoma therapy. BMC Cancer 12:285 (2012). WB, IP . Read more (PubMed: 22788920) »

See all 4 Publications for this product

Product Wall

There are currently no Abreviews or Questions for ab19609.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"